Vladimir Badmaev – Trademark Portfolio

Entity Type: 01

Vladimir Badmaev holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include GREENSELENIUM. The owner is based in Staten Island, NY.

1440-6 Forest Hill Rd.

Staten Island, NY 10314

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Vladimir Badmaev's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Vladimir Badmaev have?

Vladimir Badmaev has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending, 1 abandoned, 2 cancelled.

What trademark classes does Vladimir Badmaev file in?

Vladimir Badmaev files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Vladimir Badmaev's most well-known trademarks?

Vladimir Badmaev's registered trademark portfolio includes well-known marks such as GREENSELENIUM. These are among 1 currently registered trademark in the portfolio.

What is Vladimir Badmaev's trademark registration success rate?

Vladimir Badmaev has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 2 applications are pending review.